Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
RhinoSédal is a medical device developed by Laboratoires Élerté, specifically designed for the symptomatic treatment and hygiene of nasal conditions such as rhinitis, rhinopharyngitis, and general nasal congestion. As a non-pharmacological intervention, it functions primarily through mechanical and physical actions rather than metabolic or immunological pathways. The formulation typically acts to cleanse the nasal passages, facilitate the removal of thickened mucus, and support the physiological functions of the nasal mucosa. It is often used to restore respiratory comfort and prevent secondary infections by maintaining clear airways, providing an alternative or adjunct to pharmacological vasoconstrictors and antihistamines.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on RhinoSédal.